From hushed whispers in market stalls to bold online advertisements, the demand and conversation around aphrodisiacs, popularly known as sex enhancers, have taken a new dimension.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...